Safety and Efficacy of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Critical Limb Ischemia

Gene Therapy - United Kingdom
doi 10.1038/gt.2016.9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety of a Non-Viral Plasmid-Encoding Dual Isoforms of Hepatocyte Growth Factor in Critical Limb Ischemia Patients: A Phase I Study

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Characteristics of Physical Activity in Patients With Critical Limb Ischemia

Journal of Physical Therapy Science
Physical TherapySports TherapyRehabilitation
2016English

Increased Incidence of Cancer in Japanese Patients With Critical Limb Ischemia

Annals of Vascular Diseases
2019English

Perioperative Platelet and Monocyte Activation in Patients With Critical Limb Ischemia

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2010English

Clinical Efficacy of Endovascular Therapy for Patients With Critical Limb Ischemia Attributable to Pure Isolated Infrapopliteal Lesions

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

Therapeutic Potential of Hepatocyte Growth Factor Against Cerebral Ischemia (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Current Status of Infrapopliteal Artery Stenting in Patients With Critical Limb Ischemia

Jornal Vascular Brasileiro
Cardiovascular MedicineCardiology
2008English

Global Vascular Guidelines for Patients With Critical Limb-Threatening Ischemia

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Global Vascular Guidelines for Patients With Critical Limb-Threatening Ischemia

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy